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Condensation 38 
Sleep disordered breathing is associated with a higher risk of adverse intrapartum and 39 
perinatal outcomes. 40 
 41 
Short Title 42 
Sleep disordered breathing in pregnancy - Systematic review and meta-analysis  43 
 44 
Implications and Contributions 45 
• This study was conducted to evaluate a common sleep disorder that is increasingly 46 
prevalent in pregnancy given the rise in maternal obesity rates.  47 
• The results clearly indicate that intrapartum and perinatal outcomes in women with 48 
sleep-disordered breathing are significantly worse compared to controls and 49 
emphasize the high risk nature of these women.  50 
• As sleep-disordered breathing in pregnancy is generally under diagnosed, this review 51 
highlights the need to develop effective and timely screening and surveillance 52 
processes in this cohort of women.   53 
 54 
Key words: meta-analysis, obstructive sleep apnea, pregnancy outcomes, sleep disordered 55 
breathing, snoring, systematic review, birth weight, cesarean delivery, instrumental 56 
operative delivery, cord artery pH, Apgar score, neonatal nursery admission, stillbirth, 57 
perinatal death. 58 
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Abstract 59 
Background 60 
Sleep-disordered breathing is an increasingly common condition in non-obstetric 61 
populations and is associated with significant morbidity. The incidence of sleep-disordered 62 
breathing in pregnancy is unknown and it is likely that many cases go undiagnosed.  63 
Objective 64 
A systematic review and meta-analysis was undertaken to determine if pregnant women 65 
diagnosed with sleep-disordered breathing are more likely to have adverse intrapartum and 66 
perinatal outcomes compared to controls.  67 
Study Design 68 
PubMed, Embase and Cinahl databases were searched for full text publications in English of 69 
sleep-disordered breathing and human pregnancy up to June 2017.  Only studies that 70 
reported on sleep-disordered breathing in relation to gestational age or birth weight at 71 
delivery, pre-term birth, mode of delivery, cord pH, Apgar score, nursery admission, stillbirth 72 
or perinatal death, meconium at delivery or wound complications were included.  73 
Results 74 
A total of 1576 results were identified with 33 studies meeting inclusion criteria. Women 75 
with sleep-disordered breathing were older (mean difference 1.66, 95% confidence interval 76 
1.04 – 2.28) and had a higher body mass index (mean difference 3.31, 95% confidence 77 
interval 2.30 – 4.32) than those that did not. Maternal sleep-disordered breathing was 78 
significantly associated with pre-term birth (<37 weeks gestation) (odds ratio 1.86, 95% 79 
confidence interval 1.50 – 2.31) and low birth weight (<2500g) (odds ratio 1.67, 95% 80 
confidence interval 1.00 - 2.78). These women were also less likely to have a vaginal delivery 81 
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(odds ratio 0.61, 95% confidence interval 0.48 - 0.78) and at a higher risk of having an 82 
assisted vaginal delivery (odds ratio 1.88, 95% confidence interval 1.10 – 3.21) or a cesarean 83 
(odds ratio 1.81, 95% confidence interval 1.55 – 2.11). The risk of both elective (odds ratio 84 
1.38, 95% confidence interval 1.09 - 1.76) and emergency cesarean (odds ratio 2.52, 95% 85 
confidence interval 1.20 – 5.29) was increased. In addition, women with sleep disordered 86 
breathing were at a higher risk of having an infant with a 5-minute Apgar score <7 (odds 87 
ratio 2.14, 95% confidence interval 1.24 – 3.71), stillbirth or perinatal death (odds ratio 2.02, 88 
95% confidence interval 1.25 - 3.28), and neonatal nursery admission (odds ratio 1.90, 95% 89 
confidence interval 1.38 – 2.61). 90 
 91 
Conclusion 92 
Maternal sleep-disordered breathing is associated with increased risks of adverse 93 
intrapartum and perinatal outcomes.  94 
 95 
 96 
  97 
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Introduction 98 
Sleep disordered breathing (SDB) incorporates a spectrum of respiratory and ventilation 99 
abnormalities that range from snoring to obstructive sleep apnea (OSA). OSA is 100 
characterised by partial or complete repetitive airway collapse resulting in intermittent 101 
hypoxic episodes. In non-obstetric populations, SDB is associated with hypertension as well 102 
as cardiovascular and metabolic diseases.
1
 In pregnancy however, specific hormonal and 103 
physiological changes that occur over gestation predispose women to SDB or can 104 
exacerbate its symptoms, with increasing appreciation that aberrant maternal sleep is a risk 105 
factor for adverse obstetric and perinatal outcomes.
 2
 
3
 
4-7
  106 
The incidence of SDB during pregnancy is unknown and it is likely that many cases go 107 
undiagnosed. This may be due to the belief by both pregnant women and their clinicians, 108 
that manifestations of SDB are the normal sequelae of the physiological and emotional 109 
changes associated with pregnancy.
8
 There are several reviews
5-7,9
 showing an association 110 
between SDB and pregnancy complications including pregnancy induced hypertension, pre-111 
eclampsia (PE), gestational diabetes, fetal growth restriction (FGR) and pre-term birth 112 
however there is a paucity of data specifically regarding intrapartum and perinatal 113 
outcomes.  114 
The aim of this systematic review and meta-analysis thus was to determine the association 115 
between SDB in pregnancy and adverse intrapartum and perinatal outcomes. 116 
Methods 117 
A systematic review and meta-analysis of observational cohort and case-control studies up 118 
to June 2017 that reported the association between SDB and obstetric and perinatal 119 
outcomes was performed. Relevant studies were identified through a search of electronic 120 
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databases PubMed, Cinahl, and Embase and through the reference lists from relevant 121 
identified studies and systematic reviews. We used a combination of key words and MESH 122 
terms including "sleep apnea”, “obstructive", "sleep disturbance", “OSA”, "sleep medicine", 123 
“SDB”, “apnoea”, “apnea”, "sleep disordered breathing", “snoring”, “pregnancy”, 124 
“pregnant”, “maternal” and “obstetric”. We limited the search to studies published in 125 
English. The first reviewer (N.B.) screened all titles and extracted those citations requiring 126 
more detailed examination. A second review of abstracts and citations was performed by 127 
two reviewers (N.B. and J.T.) who went on to read and select all relevant trials for inclusion 128 
and extract the study data in duplicate. Results that were conference abstracts or posters, 129 
case reports with less than ten participants, dissertations or reviews were excluded. 130 
Reference lists of included publications were manually searched for relevant citations not 131 
found in the initial electronic search. When any disagreement between the opinions of the 132 
two reviewers arose, a further assessment of that study was performed by a third reviewer 133 
(S.K.). This study was performed in keeping with the PRISMA guidelines.
10
  134 
Obstetric outcomes assessed included gestational age at delivery, pre-term birth (PTB) (<37 135 
weeks), mode of, and indication for delivery, meconium stained amniotic fluid and wound 136 
complications. Perinatal outcomes were birth weight (BW), cord artery pH, 5-minute Apgar 137 
score <7, admission to the neonatal intensive care unit (NICU) or special care nursery (SCN) 138 
and stillbirth or perinatal death. 139 
Studies were included if they employed objective measures of diagnosis as well as those 140 
that used self-reported questionnaires. Objective diagnostic methods included standard 141 
polysomnography (PSG), in-home portable polysomnography, ambulatory sleep evaluation 142 
using an appropriate device (e.g. WatchPAT 200
TM
) or pulse oximetry.  143 
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Studies that used self-reported questionnaires were included only if they reported both an 144 
assessment of sleep quality and the outcomes of interest. Some studies employed 145 
standardised questionnaires including the Berlin Questionnaire (BQ),
11
 Epworth Sleepiness 146 
Scale (ESS),
12
 Pittsburgh Sleep Quality Index (PSQI),
13
 and Sleep and Health Questionnaire 147 
(SHQ) which is a modified version of the Specialised Centres of Research (SCOR) Sleep 148 
Questionnaire,
14
 whilst others used questionnaires of their own design, most commonly to 149 
assess snoring. For the purpose of this review, snorers were considered to have SDB.  150 
For studies that utilised PSG, an Apnea Hypopnea Index (AHI) >5/hr, was considered to 151 
represent the SDB group.  This is the standard threshold according to the American 152 
Academy of Sleep Medicine for OSA, with further categorization of severity as follows - an 153 
AHI <5 is normal, ≥5 – 14 (mild sleep apnea), ≥15 - 29 (moderate sleep apnea), and ≥30 154 
(severe sleep apnea).
15,16
  For studies using the PSQI, a score of >5 was considered to 155 
represent the SDB group while controls had a PSQI score or <5.
13
 For studies that assessed 156 
outcomes in both the second and third trimesters, only data from the third trimester were 157 
included. 158 
Studies were also only included if they reported raw data that could be included in a meta-159 
analysis. Studies that reported outcomes using a mean with no standard deviation were 160 
excluded, as were studies that reported a rate rather than a total number of events, or 161 
grouped events in categories without enough information to extract the data.  162 
Statistical Analysis 163 
Review Manager (RevMan) 5.3.5 software (The Nordic Cochrane Centre, The Cochrane 164 
Collaboration, 2014) was used to perform the statistical analysis. A random effects analysis 165 
model was utilized with mean difference calculations for continuous variables and odds 166 
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ratio calculations for dichotomous data. Odds ratios (OR) were calculated for each study and 167 
were pooled for global analysis using Der Simonian and Laird models to generate odds ratios 168 
and 95% confidence intervals (CIs). Where possible adjusted odds ratios were calculated by 169 
the inverse variance method using adjusted ORs detailed in the included studies. Adjusted 170 
ORs were pooled even when they had been adjusted for different variables as it was felt this 171 
would better represent the true effect than unadjusted ratios alone. Subgroup analysis was 172 
performed according to method of diagnosis, i.e. subjective (questionnaire based) or 173 
objective testing, when there was a minimum of 4 included studies in each subgroup. 174 
Heterogeneity between the studies was assessed using the Higgins I
2
 statistic and deemed 175 
moderate if >50% and high if >75%. The I
2
 quantity delineates the percentage of total 176 
variation between studies due to heterogeneity as opposed to chance.
17
  177 
Assessment of quality and bias 178 
The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in 179 
meta-analyses
18
 was employed in order to assess study quality. Assessments were made in 180 
three categories: selection of study participants, comparability of study groups and 181 
reporting and determination of outcomes. Each study was graded as per the NOS coding 182 
manual and assigned a star rating based on the study fulfilling the specified criteria. Studies 183 
were determined to be of high risk of bias if the NOS score was <6. A sensitivity analysis was 184 
performed to evaluate the effect of SDB upon outcomes after exclusion of low quality 185 
studies: 1) studies with high risk of bias 2) studies with a subjective method for diagnosing 186 
SDB.  Funnel plots were generated to assess effect of publication bias. 187 
Results 188 
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The initial electronic search returned 1576 citations. After the removal of duplicates 1472 189 
citations were reviewed and from these 58 potential studies were included for full review. A 190 
total of 33 studies containing 963,310 participants met the inclusion criteria and were used 191 
for the final analysis. (Figure 1a)  192 
Description of studies 193 
Of the thirty three included studies,
19-51
 the diagnosis of SDB was made using objective 194 
means in 8 studies
20,25,34,35,37,43,45,50
, self-reported questionnaires in 21 studies,
19,23,24,26-
195 
30,32,33,36,38-42,44,46,48,49,51
 and retrospectively determined from a database in 4 studies.
21,22,31,47
  196 
A summary of the included studies can be seen in table 1. The Higgins I
2 
values can be seen 197 
in table 2. Of these, the I
2 
value is low for 7 outcomes, moderate for 10 outcomes and high 198 
for 1 outcome.   199 
Bias assessment revealed the majority of studies scored highly in the participant selection 200 
and outcome assessment categories. The comparability category was where the most 201 
variability between studies was observed with many studies not adjusting for confounders, 202 
particularly body mass index (BMI) (Figure 1b)  203 
Assessment of funnel plots suggested publication bias was unlikely as small studies were 204 
reporting equally positive and negative correlations for the outcomes of interest. 205 
(Supplementary figure 1) 206 
Sensitivity analysis was performed for all outcomes of interest after excluding low-quality 207 
studies. Whilst exclusion of studies deemed to have a high risk of bias (NOS score <6) did not 208 
affect the significance of any of the outcomes of interest, exclusion of studies that used a 209 
subjective method for diagnosing SDB did alter the results of two outcomes: low birth 210 
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weight and 5-minute Apgar score <7. Low birth weight (<2500g) was significant when all 211 
results were pooled (OR 1.67, 95% CI 1.0-2.78, p=0.05), however was not significant when 212 
subjective methods of diagnosis were excluded from the analysis (OR 1.27, 95% CI 0.72-213 
2.25, p=0.41). Similarly, whilst 5-minute Apgar score <7 was significantly increased among 214 
women with SDB in the pooled analysis (OR 2.14, 95% CI 1.24-3.71, p=0.006), this was no 215 
longer significant after excluding those studies that used a subjective method for diagnosing 216 
SDB (OR 3.16, 95% CI 0.78-12.73, p=0.11). It should be noted however, that for both these 217 
outcomes there were only 2 and 3 studies in each of the objective methods of diagnosis 218 
subgroups. 219 
Meta-analysis 220 
Maternal Age and BMI 221 
Maternal age was reported in 19 studies
20,24,25,28,30,31,33-35,37,38,42-45,48-51
 and pre-pregnancy 222 
BMI in 17 studies.
20,25,30,31,33-38,43-45,48-51
 Women with SDB were more likely to be older (MD 223 
1.66, 95% CI1.04 – 2.28, p<0.00001) and have a higher BMI (MD3.31, 95% CI2.30 – 4.32, 224 
p<0.00001) compared to controls. (Figure 2) 225 
Gestational age at delivery and pre-term birth 226 
There were 17 studies
20,22,24,25,31,34-36,38,40,43-45,48-51
 that reported gestational age at delivery - 227 
8
24,36,38,40,44,48,49,51
 used questionnaire based assessment of SDB and 9
20,22,25,31,34,35,43,45,50
 228 
used objective assessment methods. Women with SDB delivered earlier compared to 229 
controls (MD -0.19, 95% CI -0.36 - - 0.03, P = 0.02). (Figure 3a) There were 17 studies
19,21-
230 
23,26,28-30,33-36,39,40,43,46,47
 that specifically reported PTB as an outcome. Eleven
19,23,26,28-
231 
30,33,36,39,40,46
 used questionnaire based assessments and 6
21,22,34,35,43,47
 used objective 232 
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assessment methods. The risk of PTB was significantly higher in women with SDB compared 233 
to those without (OR 1.86, 95% CI1.50 – 2.31, p<0.00001). (Figure 3b) 234 
Birth weight 235 
BW was assessed in 21 studies.
20,22,25,28,30-38,40,43-45,48-51
  Eleven
28,30,32,33,36,38,40,44,48,49,51
 of 236 
these used questionnaire based assessment methods while 10 studies
20,22,25,31,34,35,37,43,45,50
 237 
used objective assessment techniques. No statistically significant difference in BW was 238 
demonstrated (MD -13.84, 95% CI -57.08 – 29.40, p=0.53) although there was a trend 239 
towards a lower BW in SDB women which was more marked in studies that used objective 240 
assessment of SDB (MD -54.75, 95% CI -121.03 – 11.53, p=0.11) as opposed to questionnaire 241 
based studies (MD 8.22, 95% CI -39.77 – 56.22, p=0.74). (Figure 3c) 242 
Small for gestational age/Low Birth weight 243 
Small-for-gestational-age (SGA) (defined as BW <10
th
 centile) was reported by 21 studies.
19-
244 
22,24-26,29,30,33,35-37,40,41,43-46,49,51
 Of these, 13 studies
19,24,26,29,30,33,36,40,41,44,46,49,51
 used 245 
questionnaire based assessment and 8 studies
20-22,25,35,37,43,45
 used objective methods to 246 
define SDB. The results for this outcome did not reach statistical significance when pooled 247 
(OR 1.19, 95% CI 0.94 – 1.51, p=0.16) or when analysed separately -questionnaire based 248 
assessment (OR 1.15, 95% CI 0.86 – 1.54, p=0.33) or objective assessment (OR 1.31, 95% CI 249 
0.8 – 2.14, p=0.29), although there was a trend towards SGA being more common in SDB 250 
women. (Figure 3d) 251 
Seven studies
22,23,26,31,36,42,49
 defined low birth weight as birth weight <2500g. The risk of 252 
BW<2500g was significantly higher in women with SDB (OR 1.67, 95% CI 1.00 – 2.78, p=0.05) 253 
(Figure 3e) when the results were pooled. However, this did not remain significant when the 254 
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data was analysed separately - objective assessment methods (OR 3.75, 95% CI 0.73-19.3, 255 
p=0.12) and questionnaire based methods (OR 1.27, 95% CI 0.72-2.25, p=0.41). 256 
Apgar score <7 at 5 minutes, NICU/SCN admission, Stillbirth/Perinatal death, Acidosis 257 
Five-minute Apgar score <7 as an outcome was reported in 11 258 
studies,
21,22,24,25,27,29,40,41,46,49,51
 NICU/SCN admission in 9 studies,
19,21,25,29,34,35,40,42,45
 259 
stillbirth/perinatal death in 6 studies 
21,32,34,35,42,47
 and cord pH in 5 studies.
20,37,40,48,50
  260 
Women with SDB were more likely to have a 5-minute Apgar score <7 (OR 2.14, 95% CI 1.24 261 
– 3.71, p= 0.006). (Figure 4a) These women also had a significantly higher risk of stillbirth or 262 
perinatal death (OR 2.02, 95% CI 1.25 – 3.28, p=0.004) (Figure 4b) as well as higher risks of 263 
admission to NICU/SCN (OR 1.90, 95% CI 1.38 – 2.61, p<0.0001. (Figure 4c) There was no 264 
significant difference between the SDB and control groups (MD -0.02, 95% CI -0.05 - -0.00, 265 
p=0.07) for acidosis at birth. (Figure 4d) 266 
Meconium stained amniotic fluid 267 
Meconium stained amniotic fluid was reported in 4 studies.
30,33,41,51
  There was no 268 
difference identified between the SDB cohort and controls (OR 2.68, 95% CI 0.88 – 8.20, 269 
p=0.08). (Figure 5f) 270 
Wound complications 271 
Two studies
34,47
 reported this outcome. Women with SDB were at a higher risk of having 272 
postoperative wound complications (OR 3.67, 95% CI 1.82 – 7.40, p=0.0003). (Figure 3f)) 273 
Mode of birth 274 
Mode of birth was categorized into vaginal, assisted vaginal, cesarean, elective cesarean and 275 
emergency cesarean birth. Vaginal birth was reported in 10 studies,
20,21,23,28,32,37,38,40,46,50
 276 
assisted vaginal in 6 studies,
20,28,32,37,46,50
 cesarean birth in 18 studies
20-
277 
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23,26,28,29,32,34,35,37,38,40,42,46,47,50,51
 and a further 4 studies
32,37,40,46
 distinguished between 278 
elective and emergency cesarean procedures. Women with SDB were less likely to achieve a 279 
vaginal delivery (OR 0.61, 95% CI 0.48 – 0.78, p<0.0001) (Figure 5a) and more likely to have 280 
an assisted vaginal birth (OR 1.88, 95% CI 1.10 – 3.21, p=0.02) (Figure 5b) compared to 281 
controls. They were also more likely to have a cesarean (OR 1.81, 95% CI 1.55 – 2.11, 282 
p<0.00001), (Figure 5c) both elective (OR 1.38, 95% CI 1.09 – 1.76, p=0.008) (Figure 5d) and 283 
emergency (OR 2.52, 95% CI 1.20 – 5.29, p=0.01). (Figure 5e) 284 
Subgroup analysis 285 
The total number of participants included in this meta-analysis was 963,310. However, of 286 
these, 941,228 came from two large retrospective studies – one a population based study 287 
and the other based in military hospitals.
21,47
 Given the heavy weightage of these two 288 
studies to the overall numbers, we also re-analysed the data excluding these two studies to 289 
assess their impact on our initial findings. The following outcomes remained unchanged 290 
after exclusion of these 2 large studies: PTB (OR 1.75, 95% CI 1.34 – 2.29, p<0.0001), 291 
SGA/LBW <10
th
 centile (OR 1.26, 95% CI 0.99 – 1.60, p=0.06), 5-minute Apgar score <7 (OR 292 
2.17, 95% CI 1.01 – 4.68, p=0.05), NICU/SCN admission (OR 1.95, 95% CI 1.28 – 2.96, 293 
p=0.002), vaginal delivery (OR 0.64, 95% CI 0.46 – 0.89, p=0.008), cesarean birth (OR 1.71, 294 
95% CI 1.47 – 2.00, p<0.00001) and wound complications. However, stillbirth/perinatal 295 
death was no longer significant (OR 1.14, 95% CI 0.35 – 3.69, p=0.83) after exclusion of 296 
these two large studies likely due to the small number of remaining studies
32,34,35,42
 with 297 
combined participant numbers of only 515 reporting this specific outcome.  298 
The Higgins I
2
 statistic for heterogeneity in this subgroup-analysis remained above 50% 299 
(moderate heterogeneity) for PTB, 5-minute Apgar score <7, nursery admission and vaginal 300 
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delivery. For the outcomes of LBW <10
th
 centile and cesarean birth there was a reduction in 301 
the I
2 
statistic to <50% (low heterogeneity) whilst it remained low for both wound 302 
complications and stillbirth/perinatal death.  303 
Meta-analysis adjusted for confounders 304 
There were a total of 14
19,21,22,24,26,29,34-37,39-41,47
 studies that reported outcomes which had 305 
been adjusted for confounders. Of these, only seven
22,24,34,37,39,40,47
 were able to be included 306 
in a further meta-analysis. A meta-analysis controlling for confounders was only able to be 307 
performed for three specific outcomes: low birth weight (LBW) (defined as BW <10
th
 308 
centile), pre-term birth and cesarean delivery due to the low numbers of papers that 309 
reported raw data and adjusted odds ratios. While each paper adjusted for different 310 
confounders (table 1), all adjusted for either BMI, maternal weight or obesity, and all except 311 
one
37
 adjusted for maternal age.  All three outcomes were significant after adjusting for 312 
maternal BMI and maternal age: pre-term birth (OR 2.00, CI 1.49 – 2.68, p<0.00001), 313 
cesarean birth (OR 1.73, CI 1.52 – 1.98, p<0.00001) and SGA (BW <10
th
 centile) (OR 1.54, CI 314 
1.19 – 1.99, p=0.001). (Figure 6) 315 
Comment 316 
Principal findings and implications for clinical practice 317 
The results of this systematic review and meta-analysis clearly demonstrate poorer 318 
intrapartum and perinatal outcomes in women with SDB compared to controls and 319 
emphasize the high-risk profile of this cohort. Women with SDB were more likely to be 320 
older, have a higher BMI and were at higher risk of PTB, cesarean birth and postoperative 321 
wound complications. They were also much less likely to achieve an uncomplicated vaginal 322 
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birth. Infants of women with SDB were also more likely to be LBW, have an Apgar score <7 323 
at 5 minutes, require admission to the NICU or die in the perinatal period.  324 
The mechanisms responsible for these poorer outcomes have not yet been fully elucidated. 325 
However, the association between SDB and intermittent maternal hypoxia as well as the link 326 
with conditions synonymous with impaired placental function such as pre-eclampsia suggest 327 
a multifactorial etiology, with both physiological changes associated with pregnancy and 328 
placental dysfunction involved. Given the increased risk of low birth weight and preterm 329 
birth in this cohort, it is not surprising that the risk for operative birth and poorer perinatal 330 
outcomes are consequently elevated.   331 
These are important findings that have clear implications for obstetric practice. Firstly, given 332 
the rapidly increasing worldwide obesity rates, SDB is likely to become more prevalent in 333 
the pregnant population and is worthy of being screened for. Secondly, the increased risk 334 
for both adverse intrapartum and perinatal outcomes demonstrated in this review strongly 335 
support the need for increased surveillance of this cohort.  Thirdly, public health education 336 
programs need to take into account the specific maternal and perinatal risks and promote 337 
education about the significance of OSA symptoms and the need for women to discuss this 338 
with their obstetric caregivers.  Furthermore, given the association between SDB and 339 
perinatal death there also needs to be appropriate determination for treatment options and 340 
the optimum gestation for birth to mitigate this complication. 341 
Available evidence suggests that symptoms of SDB increase with gestational age
52
 and 342 
resolve after birth.
53
 The increased mucosal edema of the upper respiratory tract and 343 
elevation of the diaphragm resulting in decreased functional residual capacity, changes to 344 
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REM sleep, increased sympathetic activation as well as inflammation and oxidative stress 345 
can cause obstructive sleep apnea (OSA) and intermittent hypoxia.
8,54
 In animal studies
55,56
 346 
intermittent periods of hypoxia during pregnancy can result in the birth of growth restricted 347 
pups.   348 
Currently there is no consensus on the best method to assess maternal sleep disorders in 349 
pregnancy, nor indeed the ideal gestation at which to make this assessment given that SDB 350 
symptoms worsen as pregnancy progresses.
52
  Although there is some evidence that 351 
maternal continuous positive air way pressure (CPAP) treatment may be beneficial in 352 
lowering blood pressure in women with pre-eclampsia and pre-existing hypertension,
57,58
 353 
what is not known is if treatment ameliorates the risks of other complications demonstrated 354 
in this meta-analysis if maternal hypertension is not present. There is also some evidence 355 
that the use of nocturnal nasal CPAP improves fetal movement in women with pre-356 
eclampsia.
59
 Although the mechanism for this is not clearly elucidated it is possible that fetal 357 
oxygenation is improved by a combination of improved maternal oxygenation and placental 358 
perfusion. 359 
In the United States the prevalence of SDB is increasing
60
 and is likely to be related to rising 360 
obesity rates. In Australia, a similar trend is also evident with  63% of Australians aged >18 361 
years being overweight or obese
61
 with maternal obesity associated with a myriad of 362 
obstetric and perinatal complications.
62
 Given the strong association between maternal 363 
obesity and SDB it may be reasonable that overweight and obese women be assessed for 364 
obstructive sleep disorders and where appropriate be considered for prenatal CPAP 365 
treatment.  366 
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In addition to sleep disorders impacting on intrapartum and perinatal outcomes, there is 367 
emerging literature suggesting that maternal sleep position may also influence stillbirth 368 
rates.
42,63-65
 Although maternal sleep position was not the focus of our study, this is clearly 369 
an important area that warrants further investigation. 370 
Strengths and limitations 371 
The strengths of this meta-analysis lie in its large number of participants and the clinically 372 
relevant intrapartum and perinatal outcomes reported. Given the potential confounding 373 
effects of the pre-dominant contribution to the number of participants from just two 
21,47
 374 
studies we still managed to show that with the exception of perinatal death the risks of 375 
adverse outcomes associated with SDB in pregnancy remained elevated.  376 
Any meta-analysis is inherently limited by the type and quality of studies included and their 377 
reporting style. In our meta-analysis, despite the variation of studies included, sensitivity 378 
analyses of the impact of risk of bias did not significantly influence the outcomes of interest. 379 
We were also limited by the fact that not all studies reported results that had been adjusted 380 
for relevant confounders particularly maternal age and BMI which are important factors 381 
influencing SDB. Regardless of this, the separate meta-analysis of 7 studies (Figure 6) clearly 382 
shows that women with SDB remain at higher risk for a LBW baby, PTB and cesarean birth 383 
even after adjustment for confounders.  384 
Additional sensitivity analysis was performed to address the possible impact of different 385 
methods for diagnosis SDB. With the exception of the outcomes of low birth weight <10
th
 386 
centile and 5-minute Apgar <7, our results suggest that SDB is a significant risk factor for 387 
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adverse outcomes and supports the inclusion of both subjective and objective studies within 388 
this review. 389 
Conclusions and implications for future research 390 
Although this review shows that women with SDB are at increased risk of intrapartum and 391 
perinatal complications there remains large evidence gaps which need to be urgently 392 
addressed given the evolving global obesity demographic. Firstly, accurate diagnostic 393 
criteria and AHI thresholds for SDB in pregnancy needs to be established. Secondly, the 394 
optimum treatment during gestation needs further clarification and most importantly, to 395 
ascertain if treatment of SDB actually improves outcomes. Thirdly, feto-placental 396 
hemodynamics in women with SDB requires more research to clarify if there are specific at-397 
risk cohorts that are more vulnerable to complications than others. Finally, the optimum 398 
gestation for birth and the best intrapartum management processes need to be determined. 399 
Larger studies are clearly needed to evaluate these questions. 400 
  401 
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Table 1 Summary of included studies 1 
Study ID 
First 
author, 
year 
published 
Participant numbers Assessment 
method 
Test type Reported maternal 
demographics 
Covariates 
in adjusted 
analyses 
reported  
Outcomes 
of interest 
reported 
Total SDB Control   BMI Age   
Antony 
2014
19
 
1153 383 770 Questionnai
re 
ESS, BQ No No Maternal 
age, 
race/ethnici
ty, smoking, 
parity, GA, 
BMI, 
hypertensio
n, pre-
gestational 
and 
gestational 
diabetes * 
SGA <10% 
at delivery, 
nursery 
admission, 
PTB 
Bassan 
2016
20
 
44 11 33 Objective WatchPat Yes Yes NA GA at 
delivery, 
BW at 
delivery, 
SGA <10% 
at delivery, 
acidosis at 
birth, mode 
of delivery 
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Bin 2016
21
 636227 519 635708 Objective – 
hospital 
records 
Hospital 
records 
Yes* Yes* Maternal 
age, 
country of 
birth, 
smoking, 
obesity, 
parity, 
socioecono
mic 
disadvantag
e, chronic 
hypertensio
n, pre-
existing 
diabetes, 
gestational 
diabetes, 
pregnancy 
hypertensio
n * 
SGA <10% 
at delivery, 
5-min 
Apgar <7, 
mode of 
delivery, 
nursery 
admission, 
PTB, 
stillbirth / 
perinatal 
death 
Chen 
2012
22
 
4746 791 3955 Objective – 
hospital 
records 
Hospital 
records 
Yes* Yes* Maternal 
age, 
maternal 
education, 
marital 
status, 
gestational 
diabetes, 
gestational 
hypertensio
GA at 
delivery, 
BW at 
delivery, 
SGA <10% 
at delivery, 
LBW 
<2500g, 5-
min Apgar 
<7, mode of 
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n, anaemia, 
coronary 
heart 
disease, 
hyperlipide
mia, 
obesity, 
geographic 
region, 
paternal 
age, infant 
gender, 
parity. 
delivery, 
PTB 
Dolatian 
2014
23
 
231 119 112 Questionnai
re 
ESS Yes* Yes* NA LBW 
<2500g, 
mode of 
delivery, 
PTB 
Franklin 
2000
24
 
502 113 389 Questionnai
re 
Snoring 
questionnai
re 
No Yes Maternal 
weight, age 
& smoking 
habits 
GA at 
delivery, 
SGA <10% 
at delivery, 
5-min 
Apgar <7 
Fung 2013
25
 41 14 27 Objective PSG Yes Yes NA GA at 
delivery, 
BW at 
delivery, 
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SGA <10% 
at delivery, 
5-min 
Apgar <7, 
nursery 
admission 
Ge 2016
26
 3079 511 2568 Questionnai
re 
Snoring 
questionnai
re 
Yes* Yes* Maternal 
age, 
education 
level, 
gravidity, 
only child 
or not, 
maternal 
smoking 
and BMI * 
SGA <10% 
at delivery, 
LBW 
<2500g, 
mode of 
delivery, 
PTB 
Higgins 
2011
27
 
4074 1343 2731 Questionnai
re 
BQ Yes* Yes* NA 5-min 
Apgar <7 
Hung 
2014
28
 
120 79 41 Questionnai
re 
PSQI No Yes NA BW at 
delivery, 
mode of 
delivery, 
PTB 
Ko 2013
29
 276 89 187 Questionnai
re 
BQ No No Gravidity, 
gestational 
age, 
maternal 
SGA <10% 
at delivery, 
5-min 
Apgar <7, 
mode of 
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age * delivery, 
nursery 
admission, 
PTB 
Koken 
2007
30
 
83 40 43 Questionnai
re 
ESS, BQ Yes Yes NA BW at 
delivery, 
SGA <10% 
at delivery, 
PTB, 
meconium 
at delivery 
Lee 2017
31
 91 27 64 Objective – 
hospital 
records 
PSG from 
hospital 
records 
Yes Yes NA GA at 
delivery, 
BW at 
delivery, 
LBW 
<2500g 
Leung 
2005
32
 
112 13 99 Questionnai
re 
ESS, SHQ No No NA BW at 
delivery, 
mode of 
delivery, 
stillbirth / 
perinatal 
death 
Loube 
1996
33
 
350 49 301 Questionnai
re 
ESS, Hawaii 
Scale 
Yes Yes NA BW at 
delivery, 
SGA <10% 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
28 
 
 
 
at delivery 
PTB, 
meconium 
at delivery 
Louis 
2012
34
 
161 26 135 Objective Portable 
home PSG 
Yes Yes Maternal 
age, race, 
BMI 
GA at 
delivery, 
BW at 
delivery, 
mode of 
delivery, 
nursery 
admission, 
PTB, 
stillbirth / 
perinatal 
death, 
maternal 
wound 
complicatio
ns 
Louis 
2010
35
 
171 57 114 Objective PSG Yes Yes Maternal 
age, race, 
ethnic 
background
, tobacco 
use, type of 
insurance, 
obesity, 
hypertensio
GA at 
delivery, 
BW at 
delivery, 
SGA <10% 
at delivery, 
mode of 
delivery,  
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n, diabetes 
* 
nursery 
admission, 
PTB, 
stillbirth / 
perinatal 
death 
Micheli 
2011
36
 
940 48 892 Questionnai
re 
ESS, Snoring 
questionnai
re 
Yes Yes* Maternal 
age, 
education, 
BMI, 
smoking 
status * 
GA at 
delivery, 
BW at 
delivery, 
SGA <10% 
at delivery, 
LBW 
<2500g, 
PTB 
Miyagawa 
2011
37
 
179 22 157 Objective Pulse 
oximetry 
Yes Yes Parity, 
obesity 
BW at 
delivery, 
SGA <10% 
at delivery, 
acidosis at 
birth, mode 
of delivery 
Naghi 
2011
38
 
488 214 274 Questionnai
re 
PSQI Yes Yes NA GA at 
delivery, 
BW at 
delivery, 
mode of 
delivery 
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Na-Rungsri 
2016
39
 
1345 136 1209 Questionnai
re 
BQ Yes* Yes* Maternal 
age, BMI, 
parity, 
smoking 
status, 
previous 
PTB, 
number of 
previous 
abortion 
PTB 
O’Brien 
2013
40
 
1673 586 1087 Questionnai
re 
Snoring 
questionnai
re 
No No Maternal 
age, race, 
BMI, excess 
weight gain, 
gravidity, 
smoking, 
educational 
level, 
previous or 
family 
history of 
gestational 
hypertensio
n / PET, 
previous 
cesarean 
delivery. 
GA at 
delivery, 
BW at 
delivery, 
SGA <10% 
at delivery, 
5-min 
Apgar <7 
acidosis at 
birth, mode 
of delivery, 
nursery 
admission, 
PTB 
Olivarez 
2011
41
 
220 56 164 Questionnai
re 
ESS, BQ, 
Sleep 
No No Gravidity, 
maternal 
SGA <10% 
at delivery, 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
31 
 
 
 
schedule 
questionnai
re 
age, 
gestational 
age * 
5-min 
Apgar <7, 
meconium 
at delivery 
Owusu 
2013
42
 
220 53 167 Questionnai
re 
Snoring 
questionnai
re 
No Yes NA LBW 
<2500g, 
mode of 
delivery, 
nursery 
admission, 
stillbirth / 
perinatal 
death 
Pamidi 
2016
43
 
113 36 77 Objective PSG Yes Yes NA GA at 
delivery, 
BW at 
delivery, 
SGA <10% 
at delivery, 
PTB 
Perez 
2007
44
 
447 156 291 Questionnai
re 
Snoring 
questionnai
re 
Yes Yes NA GA at 
delivery, 
BW at 
delivery, 
SGA <10% 
at delivery 
Sahin 35 4 31 Objective PSG Yes Yes NA GA at 
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2008
45
 delivery, 
BW at 
delivery, 
SGA <10% 
at delivery, 
nursery 
admission 
Sarberg 
2014
46
 
339 72 267 Questionnai
re 
ESS, Snoring 
questionnai
re 
Yes* Yes* NA SGA <10% 
at delivery, 
5-min 
Apgar <7, 
mode of 
delivery, 
PTB 
Spence 
2017
47
 
305001 266 304735 Objective – 
hospital 
records 
Hospital 
records 
No Yes* Maternal 
age, race, 
multiple 
birth, 
hospital 
size, obesity 
Mode of 
delivery, 
PTB, 
stillbirth / 
perinatal 
death, 
maternal 
wound 
complicatio
ns 
Tauman 
2011
48
 
122 48 74 Questionnai
re 
ESS, Snoring 
questionnai
re 
Yes Yes NA GA at 
delivery, 
BW at 
delivery, 
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acidosis at 
birth 
Tauman 
2012
49
 
188 20 168 Questionnai
re 
ESS, Snoring 
questionnai
re 
Yes Yes NA GA at 
delivery, 
BW at 
delivery, 
SGA <10% 
at delivery, 
LBW 
<2500g, 5-
min Apgar 
<7 
Tauman 
2015
50
 
74 18 56 Objective WatchPat Yes Yes NA GA at 
delivery, 
BW at 
delivery, 
acidosis at 
birth, mode 
of delivery 
Ugur 2012
51
 465 69 396 Questionnai
re 
BQ Yes Yes NA GA at 
delivery, 
BW at 
delivery, 
SGA <10% 
at delivery, 
5-min 
Apgar <7, 
mode of 
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delivery, 
meconium 
at delivery 
 1 
*Due to reporting style, data could not be extracted and included in this meta-analysis 2 
SDB, sleep disordered breathing; BMI, body mass index; SGA, small for gestational age; GA, gestational age; BW, birth weight; PTB, pre-term birth; ESS, 3 
Epworth Sleepiness Scale; BQ, Berlin Questionnaire; PSG, polysomnography; PSQI, Pittsburgh Sleep Quality Index; SHQ, Sleep and Health Questionnaire. 4 
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Table 2 Table of outcomes, citations and heterogeneity 1 
Outcome of Interest 
Total 
Citations 
Citations with 
questionnaire based 
assessment 
Citations with 
objective 
assessment 
measures 
Total event 
heterogeneity 
(I
2
) 
Gestational age at 
delivery 
17 
citations 
24,36,38,40,44,48,49,
51 
20,22,25,31,34,
35,43,45,50 
56% 
Pre-term birth <37 
weeks gestation 
17 
citations 
19,23,26,28-
30,33,36,39,40,46 
21,22,34,35,43,
47 
57% 
Birth weight  21 
citations 
28,30,32,33,36,38,40,
44,48,49,51 
20,22,25,31,34,
35,37,43,45,50 
42% 
Low birth weight 
<10
th
 centile 
21 
citations 
19,24,26,29,30,33,36,
40,41,44,46,49,51 
20-
22,25,35,37,43,
45 
51% 
Low birth weight 
<2500g 
7 
citations 
23,26,36,42,49 22,31 53% 
5-min Apgar score <7 11 
citations 
24,27,29,40,41,46,49,
51 
21,22,25 47% 
Cord pH 5 
citations 
40,48 20,37,50 41% 
Stillbirth / Perinatal 
death 
6 
citations 
32,42 21,34,35,47 0% 
Neonatal intensive 
care / Special Care 
Unit admission 
9 
citations 
19,29,40,42 21,25,34,35,45 63% 
Meconium stained 
amniotic fluid 
4 
citations 
30,33,41,51  66% 
Wound complications 2 
citations 
 34,47 0% 
Vaginal delivery 10 
citations 
23,28,32,38,40,46 20,21,37,50 56% 
Overall cesarean birth 18 
citations 
23,26,28,29,32,38,40,
42,46,51 
20-
22,34,35,37,47,
50 
59% 
Elective cesarean 4 
citations 
32,40,46 37 0% 
Emergency cesarean 4 
citations 
32,40,46 37 70% 
Assisted vaginal birth 6 
citations 
28,32,46 20,37,50 0% 
Maternal BMI 17 
citations 
30,33,36,38,44,48,49,
51 
20,25,31,34,35,
37,43,45,50 
86% 
Maternal age 19 
citations 
24,28,30,33,38,42,44,
48,49,51 
20,25,31,34,35,
37,43,45,50 
55% 
 2 
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FIGURE LEGENDS 1 
Figure 1: Study quality assessment and study selection process 2 
a. Prisma Flow Diagram for selection of included studies 3 
b. The Newcastle-Ottawa Scale (NOS) for assessing study quality  4 
Figure 2: Forest plot of meta-analysis showing maternal demographics in sleep disordered breathing 5 
and control cohorts 6 
a. Maternal age 7 
b. Maternal pre-pregnancy body mass index (BMI) 8 
SDB, sleep disordered breathing; M-H, Mantel-Haenszel; SD, standard deviation; CI, confidence 9 
interval; I
2
, Higgins I
2
 statistic of heterogeneity. 10 
Figure 3: Forest plot of meta-analysis showing obstetric outcomes in sleep disordered breathing and 11 
control cohorts 12 
a. Gestational age at delivery 13 
b. Pre-term birth (<37 weeks gestation) 14 
c. Birth weight (grams) 15 
d. Low birth weight (defined as a birth weight <10
th
 centile) 16 
e. Low birth weight (defined as a birth weight <2500 grams) 17 
f. Maternal wound complications 18 
SDB, sleep disordered breathing; M-H, Mantel-Haenszel; SD, standard deviation; CI, confidence 19 
interval; I
2
, Higgins I
2
 statistic of heterogeneity. 20 
Figure 4: Forest plots of meta-analysis showing perinatal outcomes in sleep disordered breathing 21 
and control cohorts 22 
a.  5-minute Apgar score <7  23 
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b. Stillbirth / Perinatal death 1 
c. Neonatal intensive care / Special Care Unit admission 2 
d. Cord pH  3 
SDB, sleep disordered breathing; M-H, Mantel-Haenszel; SD, standard deviation; CI, confidence 4 
interval; I
2
, Higgins I
2
 statistic of heterogeneity. 5 
Figure 5: Forest plot of meta-analysis showing intrapartum outcomes in sleep disordered breathing 6 
and control cohorts 7 
a. Vaginal delivery 8 
b. Assisted vaginal deliveries 9 
c. Overall cesarean birth 10 
d. Elective cesarean  11 
e. Emergency cesarean  12 
f. Meconium stained amniotic fluid 13 
SDB, sleep disordered breathing; M-H, Mantel-Haenszel; SD, standard deviation; CI, confidence 14 
interval; I
2
, Higgins I
2
 statistic of heterogeneity. 15 
Figure 6: Forest plot of meta-analysis showing odds ratios adjusted for covariates 16 
a. Low birth weight (defined as a birth weight <10
th
 centile) 17 
b. Pre-term birth (<37 weeks gestation) 18 
c. Overall cesarean birth 19 
 20 
Supplementary Figure 1: Funnel plot for outcomes within meta-analysis 21 
a. Gestational age at delivery 22 
b. Pre-term birth (<37 weeks gestation) 23 
c. Birth weight (grams) 24 
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d. Low birth weight (defined as a birth weight <10
th
 centile) 1 
e. Low birth weight (defined as a birth weight <2500 grams) 2 
f. Maternal wound complications 3 
g. 5- minute Apgar score <7 4 
h. Stillbirth / Perinatal death 5 
i. Neonatal intensive care / Special Care Unit admission 6 
j. Cord pH 7 
k. Vaginal delivery 8 
l. Assisted vaginal deliveries 9 
m. Overall cesarean birth 10 
n. Elective cesarean birth 11 
o. Emergency cesarean birth 12 
p. Meconium stained amniotic fluid 13 
SDB, sleep disordered breathing 14 
 15 
 16 
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